Genomic surveillance of carbapenem-resistant <i>Klebsiella pneumoniae</i> in the Republic of Moldova. [PDF]
Colac S +7 more
europepmc +1 more source
Genomic and Phenotypic Insights into Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> in the Aquatic Environments of the Tibetan Plateau. [PDF]
Lu D +9 more
europepmc +1 more source
Need of an hour to tackle carbapenem-resistant <i>Klebsiella pneumoniae</i>. [PDF]
Mukhida S, Desai D.
europepmc +1 more source
Emergence of Carbapenem-Resistant Hypervirulent ST111 K63 <i>Klebsiella pneumoniae</i> in China. [PDF]
Zhu Y +9 more
europepmc +1 more source
Carbapenem-resistant <i>Acinetobacter baumannii</i> in resource-limited ICUs: when 'recommended therapy' is not realistically deliverable. [PDF]
Saquib Alam M, Khatoon N.
europepmc +1 more source
Genomic and functional characterization of a novel halophilic bacteriophage targeting carbapenem-resistant Klebsiella pneumoniae. [PDF]
Abed S +7 more
europepmc +1 more source
Carbapenem resistance in Pseudomonas aeruginosa
Carbapenem (imipenem and meropenem) resistance in Pseudomonas aeruginosa is increasing, with global resistance rates approaching 20%. The most common resistance mechanisms are down-regulation of the porin OprD, and increased activity of multi-drug efflux pumps, primarily MexAB-OprM.
openaire +1 more source
Genomic Evolution of the Increasing Prevalent Carbapenem-Resistant Hypervirulent ST15 <i>Klebsiella pneumoniae</i>. [PDF]
Fan S, Du P, Tang Y, Qi H, Liu C, Guo J.
europepmc +1 more source
Genomic Insights Into Carbapenem-Resistant Klebsiella pneumoniae in Pediatric Bloodstream Infections in Zhejiang, China (2019-2024). [PDF]
Zhou M +8 more
europepmc +1 more source
Increase in bla<sub>NDM</sub> among Carbapenemase-Producing, Carbapenem-Resistant Enterobacterales, United States, 2016-2023. [PDF]
Ansari UA +10 more
europepmc +1 more source

